Cefispiro s.r.o.

At Cefispiro s.r.o., the clinical trial portfolio focuses on respiratory tract diseases, with a strong emphasis on asthma and chronic obstructive pulmonary disease. The studies are designed to evaluate new treatment options, compare existing inhaled therapies, and improve control of symptoms and flare-ups in people living with chronic airway conditions.

• Research in severe eosinophilic asthma and severe asthma aimed at reducing serious exacerbations and improving disease control
• Studies in moderate-to-severe asthma and inadequately controlled asthma assessing whether new therapies can improve lung function and reduce attacks
• Trials in COPD and chronic bronchitis exploring approaches to lower exacerbation rates and support better long-term management

Overall, the site contributes to research on inhaled and targeted treatments that may help patients breathe more easily, reduce worsening episodes, and better manage chronic airway disease.

The asthma studies at this site cover a wide range of disease severity, from mild to moderate asthma to severe and inadequately controlled asthma. The main goal is to test whether new or improved therapies can strengthen symptom control, reduce rescue needs, and prevent worsening of the condition.

• Evaluation of novel medicines for severe eosinophilic asthma and severe asthma exacerbations
• Comparisons of inhaled combination treatments for asthma control and lung function
• Studies of treatment options for moderate-to-severe asthma in people with elevated eosinophil levels

These trials support better understanding of how to improve day-to-day management of asthma while also lowering the risk of serious flare-ups.

Research in chronic obstructive pulmonary disease at Cefispiro s.r.o. is centered on finding ways to reduce moderate and severe exacerbations in people with more advanced disease. This work also includes patients with chronic bronchitis, reflecting the site’s focus on chronic inflammatory lung conditions.

• Testing new therapies intended to lower COPD exacerbations
• Evaluating add-on treatment strategies for patients already using maintenance inhaled therapy
• Assessing whether emerging medicines can improve outcomes in moderate to very severe COPD

The research aims to support more effective long-term control of COPD and related respiratory symptoms, with the broader goal of reducing the burden of repeated flare-ups.

A notable part of the trial activity involves comparing inhaled medicines and delivery systems for asthma. These studies are designed to see whether different inhaler formulations can offer similar or better control of breathing symptoms, while also helping to simplify treatment choices for patients.

• Comparisons of inhaled combination therapies for controlled and partly controlled asthma
• Evaluation of rescue medication approaches for reducing severe asthma-related events
• Assessment of therapeutic equivalence between inhaled products used in routine respiratory care

This area of research supports practical improvements in everyday asthma management, with attention to both effectiveness and patient convenience.